Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

May 01, 2019; Volume 16,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Attarchi-tehrani, Ali

    1. You have access
      Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
      Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, Claudia Hube-Magg, Dagmar S. Lang, Martina Kluth, Maria Christina Tsourlakis, Sarah Minner, Ronald Simon, Guido Sauter, Franziska Büscheck, Frank Jacobsen, Andrea Hinsch, Stefan Steurer, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak and Doris Höflmayer
      Cancer Biology & Medicine May 2019, 16 (2) 319-330; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0384
  2. Buffa, Francesca M.

    1. You have access
      Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
      Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, Sheng Yu, Yasmin Shanneik, Elena Seraia, Djamila Ouaret, Yasuhiro Inoue, Catherine Koch, Jenny Wilding, Daniel Ebner, Anderson J. Ryan, Francesca M. Buffa and Ricky A. Sharma
      Cancer Biology & Medicine May 2019, 16 (2) 234-246; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0284
  3. Burandt, Eike

    1. You have access
      Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
      Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, Claudia Hube-Magg, Dagmar S. Lang, Martina Kluth, Maria Christina Tsourlakis, Sarah Minner, Ronald Simon, Guido Sauter, Franziska Büscheck, Frank Jacobsen, Andrea Hinsch, Stefan Steurer, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak and Doris Höflmayer
      Cancer Biology & Medicine May 2019, 16 (2) 319-330; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0384
  4. Buscheck, Franziska

    1. You have access
      Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
      Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, Claudia Hube-Magg, Dagmar S. Lang, Martina Kluth, Maria Christina Tsourlakis, Sarah Minner, Ronald Simon, Guido Sauter, Franziska Büscheck, Frank Jacobsen, Andrea Hinsch, Stefan Steurer, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak and Doris Höflmayer
      Cancer Biology & Medicine May 2019, 16 (2) 319-330; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0384
  5. Cao, Yun

    1. You have access
      Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
      Jing Si, Benlong Yang, Rong Guo, Naisi Huang, Chenlian Quan, Linxiaoxi Ma, Bingqiu Xiu, Yun Cao, Yue Tang, Linxiao Shen, Jiajian Chen and Jiong Wu
      Cancer Biology & Medicine May 2019, 16 (2) 312-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0159
  6. Carter, Rebecca

    1. You have access
      Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
      Rebecca Carter, Azadeh Cheraghchi-Bashi, Adam Westhorpe, Sheng Yu, Yasmin Shanneik, Elena Seraia, Djamila Ouaret, Yasuhiro Inoue, Catherine Koch, Jenny Wilding, Daniel Ebner, Anderson J. Ryan, Francesca M. Buffa and Ricky A. Sharma
      Cancer Biology & Medicine May 2019, 16 (2) 234-246; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0284
  7. Cavic, Milena

    1. You have access
      Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics
      Jelena Grahovac, Tatjana Srdić-Rajić, Juan Francisco Santibañez, Marijana Pavlović, Milena Čavić and Siniša Radulović
      Cancer Biology & Medicine May 2019, 16 (2) 247-263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0375
  8. Chen, Huanwen

    1. You have access
      Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies
      Jie Tian, Guanchu Liu, Chunjian Zuo, Caiyang Liu, Wanlun He and Huanwen Chen
      Cancer Biology & Medicine May 2019, 16 (2) 361-389; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0290
  9. Chen, Huoying

    1. You have access
      LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival
      Yi Que, Zhixin Fang, Yuanxiang Guan, Wei Xiao, Bushu Xu, Jingjing Zhao, Huoying Chen, Xinke Zhang, Musheng Zeng, Yao Liang and Xing Zhang
      Cancer Biology & Medicine May 2019, 16 (2) 331-340; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0306
  10. Chen, Jiajian

    1. You have access
      Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
      Jing Si, Benlong Yang, Rong Guo, Naisi Huang, Chenlian Quan, Linxiaoxi Ma, Bingqiu Xiu, Yun Cao, Yue Tang, Linxiao Shen, Jiajian Chen and Jiong Wu
      Cancer Biology & Medicine May 2019, 16 (2) 312-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0159
« Previous (Pages : 1 2 3 4 5 6 ... 16) Next »
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 16 (2)
Cancer Biology & Medicine
Vol. 16, Issue 2
1 May 2019
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire